Mangalam Drugs and Organics Ltd (MANGALAM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 138636, "name": "Mangalam Drugs", "stock_name": "Mangalam Drugs", "full_name": "Mangalam Drugs and Organics Ltd", "name_url": "stocks-analysis/mangalam-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "29.94", "chg": 0.58, "chgp": "1.98%", "dir": 1, "prev_price": "29.36", "mcapval": "47.39 Cr", "mcap": "Micro Cap", "scripcode": 532637, "symbol": "MANGALAM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE584F01014", "curr_date": "Mar 24", "curr_time": "", "bse_nse_vol": "41.65 k", "exc_status": "Active", "traded_date": "Mar 24, 2026", "traded_date_str": "2026 03 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 4.16% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3909974", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3909974.png", "date": "2026-03-24 10:00:07", "description": "At Rs 30.53, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 4.16% on 24 Mar 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3900554", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_lower_circuit_3900554.png", "date": "2026-03-19 13:00:05", "description": "Shares of Mangalam Drugs and Organics Ltd plunged sharply on 19 Mar 2026, hitting the lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical micro-cap witnessed a maximum daily loss of 4.77%, closing at ₹29.16, reflecting a significant investor sell-off amid deteriorating market sentiment and weak technical indicators." }, { "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3900233", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_mojoScore_3900233.png", "date": "2026-03-19 10:10:20", "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 19 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Mangalam Drugs Gains 10.10%: 4 Key Events Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-gains-1010-4-key-events-driving-the-weeks-rally-3892447", "imagepath": "", "date": "2026-03-15 16:01:53", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Lower circuit hit amid heavy selling pressure</p>\n <p><strong>4 Mar:</strong> Upper circuit triggered with strong buying interest</p>\n <p><strong>5 Mar:</strong> Consecutive upper circuit hit, closing at ₹30.73</p>\n <p><strong>6 Mar:</strong> Third straight upper circuit close at ₹32.37</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.32.37</div><div class=\"..." }, { "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3875412", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3875412.png", "date": "2026-03-06 10:00:07", "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 6 Mar 2026, hitting the upper circuit limit of 5%, closing at ₹32.26. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and regulatory trading restrictions." }, { "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3873109", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_mojoScore_3873109.png", "date": "2026-03-05 10:10:37", "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3873260", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3873260.png", "date": "2026-03-05 10:00:06", "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 5 Mar 2026, hitting the upper circuit limit of 5% to close at ₹30.73. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and a regulatory freeze on further price movement." }, { "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3869286", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3869286.png", "date": "2026-03-04 11:00:04", "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 4 Mar 2026, hitting the upper circuit limit of 5% and closing at ₹29.25. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and benchmark indices despite opening with a gap down." }, { "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3863948", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_lower_circuit_3863948.png", "date": "2026-03-02 10:00:07", "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 2 Mar 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The pharmaceutical company’s shares closed at ₹28.30, marking a significant intraday decline amid heightened volatility and unfilled supply, signalling growing investor apprehension in the micro-cap segment." } ], "total": 182, "sid": "138636", "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636" }, "announcements": [ { "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure", "datetime": "18-Mar-2026", "details": "Intimation of defaults under Para A sub-paragraph 6 of Schedule III- Subsequent default", "source": "BSE" }, { "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.", "datetime": "18-Mar-2026", "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 18 2026 for Shree Rasbihari Trading and Investments Pvt Ltd", "source": "BSE" }, { "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.", "datetime": "18-Mar-2026", "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 18 2026 for Aditya Ramniwas Dhoot", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17", "dt": "2017-12-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Lower circuit hit amid heavy selling pressure

4 Mar: Upper circuit triggered with strong buying interest

5 Mar: Consecutive upper circuit hit, closing at ₹30.73

6 Mar: Third straight upper circuit close at ₹32.37

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-06 10:00:07

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 6 Mar 2026, hitting the upper circuit limit of 5%, closing at ₹32.26. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and regulatory trading restrictions.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-03-05 10:10:37

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-05 10:00:06

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 5 Mar 2026, hitting the upper circuit limit of 5% to close at ₹30.73. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and a regulatory freeze on further price movement.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-04 11:00:04

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 4 Mar 2026, hitting the upper circuit limit of 5% and closing at ₹29.25. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and benchmark indices despite opening with a gap down.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-03-02 10:00:07

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 2 Mar 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The pharmaceutical company’s shares closed at ₹28.30, marking a significant intraday decline amid heightened volatility and unfilled supply, signalling growing investor apprehension in the micro-cap segment.

Read full news article